US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Emmaus Life Sciences, Inc.

0.0154

0.0000

Volume:- -

Turnover:- -

Market Cap:1.08M

PE:-0.14

High:0.0154

Open:0.0154

Low:0.0154

Close:0.0154

52wk High:0.0470

52wk Low:0.0080

Shares:70.20M

Float Shares:35.99M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1141

EPS(LYR):-0.0703

ROE:-13.36%

ROA:-1.89%

PB:-0.02

PE(LYR):-0.22

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Emmaus Life Sciences, Inc.

Exchange:

OTCQB

Establishment Date:

2000

Employees:

35

Office Location:

21250 Hawthorne Boulevard,Suite 800,Torrance,California,United States

Website:

http://www.MYndAnalytics.com

Zip Code:

90503

Phone:

Fax:

310 214 0075

Introduction:

Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMMA/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","market":"US","secType":"STK","nameCN":"Emmaus Life Sciences, Inc.","latestPrice":0.015437,"timestamp":1770840720000,"preClose":0.015437,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":35988185,"shares":70198300,"eps":-0.114131,"marketStatus":"Trading","change":0,"latestTime":"02-11 15:12:00 EST Delay","open":0.015437,"high":0.015437,"low":0.015437,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.114131,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"exchange":"OTCQB","adjPreClose":0.015437,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMMA\",,,,,undefined,":{"symbol":"EMMA","floatShares":35988185,"roa":"-1.89%","roe":"-13.36%","lyrEps":-0.070294,"shares":70198300,"dividePrice":0,"high":0.015437,"amplitude":0,"preClose":0.015437,"low":0.015437,"week52Low":0.008,"pbRate":"-0.02","psRate":"0.09","week52High":0.047,"institutionHeld":0,"latestPrice":0.015437,"eps":-0.114131,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.114131,"open":0.015437,"prevYearClose":0.013,"prevWeekClose":0.0139,"prevMonthClose":0.0139,"prevQuarterClose":0.013,"fiveDayClose":0.014,"twentyDayClose":0.0133,"sixtyDayClose":0.0091},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMMA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-19","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731992400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-11-14","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668402000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-08-15","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1660536000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2019-11-12","symbol":"EMMA","fiscalQuarterEnding":null,"expectedEps":-1.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-12","symbol":"EMMA","fiscalQuarterEnding":"2019/06","expectedEps":-1.56,"name":null,"time":"","type":"earning","dateTimestamp":1565582400000,"reportTimeType":"","actualEps":-1.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMMA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":39585025,"yearFounded":2000,"employeeNum":35,"address":"21250 Hawthorne Boulevard,Suite 800,Torrance,California,United States","zipCode":"90503","officePhone":"310 214 0065","officeFax":"310 214 0075"},"stockCompanyDetail":{"websiteUrl":"http://www.MYndAnalytics.com","stockEarnings":[{"period":"1week","weight":-0.1429},{"period":"1month","weight":-0.3498},{"period":"3month","weight":-0.7651},{"period":"6month","weight":-0.72},{"period":"1year","weight":-0.7558},{"period":"ytd","weight":-0.5219}],"description":"Emmaus Life Sciences, Inc., a commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally. The company's lead candidate is Endari, an L-glutamine oral powder to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older. It has a collaboration agreement with Kainos Medicine, Inc. for the preclinical development of Kainos' patented IRAK4 inhibitor (KM10544) as an anti-cancer drug. The company was formerly known as Emmaus Holdings, Inc. and changed its name to Emmaus Life Sciences, Inc. in September 2011. The company was founded in 2000 and is headquartered in Torrance, California.","exchange":"OTCQB","name":"Emmaus Life Sciences, Inc.","nameEN":"Emmaus Life Sciences, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EMMA\",market:\"US\",,,undefined,":null}}